# Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

> **NCT00684918** · PHASE2 · COMPLETED · sponsor: **Gemin X** · enrollment: 18 (actual)

## Conditions studied

- AML

## Interventions

- **DRUG:** Obatoclax

## Key facts

- **NCT ID:** NCT00684918
- **Lead sponsor:** Gemin X
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684918, "Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00684918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*